Skip to main content


Figure 1 | Stem Cell Research & Therapy

Figure 1

From: Predicting poor peripheral blood stem cell collection in patients with multiple myeloma receiving pre-transplant induction therapy with novel agents and mobilized with cyclophosphamide plus granulocyte-colony stimulating factor: results from a Gruppo Italiano Malattie EMatologiche dell’Adulto Multiple Myeloma Working Party study

Figure 1

Predictive risk heat-map. a) Predictive risk heat-map, applicable in individual patients, in which probabilities of failures, suboptimal and optimal collections, according to relevance of risk factors as single or combined variables, were distributed in four different and growing (from green to red) risk areas. Data were generated in the whole population of 1,348 newly diagnosed multiple myeloma patients; b) Predictive risk heat-map in patient population (number, 1,203, 89.24%) with an absolute number of circulating CD34+ PBSC >20/μl at the time of apheresis. PBSC, peripheral blood stem cells.

Back to article page